Colonis Pharma focuses on repurposing and reformulating existing medicines to address unmet clinical needs, thereby enhancing patient compliance and health outcomes. The company employs a rigorous development process to revitalize established medications, extending their lifecycle and making them more accessible to patients. By leveraging expert market analysis, Colonis identifies the demand for specific products and tailors their offerings to meet these needs, ultimately aiming to improve the quality of life for individuals requiring pharmaceutical care.

The product portfolio of Colonis Pharma includes a diverse range of value-added medicines across various therapeutic areas. Their offerings encompass formulations such as oral solutions, capsules, and chewable tablets, featuring active ingredients like acetylcysteine, melatonin, and metformin. This strategic approach not only allows Colonis to fill market gaps but also positions them as leaders in the UK pharmaceutical landscape, where they successfully commercialize their products through partnerships and a deep understanding of the healthcare system.

United Kingdom

Making Medicines More Manageable

At Colonis, we repurpose medicines to make them more manageable for patients. By identifying and understanding how unmet clinical needs impact patients, we develop innovative solutions that improve compliance and enhance health outcomes, empowering individuals to live their lives to the fullest.

Our mission is to support patients in receiving the most appropriate and accessible treatment for a better quality of life.

Colonis Pharma

Company Details